Healthcare provider profile · identity verified

Dave Santos Torres, MD

Family Practice · JOHNSTOWN, PA · NPI 1598290108

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	511	203
Lisinopril	Lisinopril	330	122
Amlodipine Besylate	Amlodipine Besylate	284	106
Levothyroxine Sodium	Levothyroxine Sodium	259	99
Losartan Potassium	Losartan Potassium	219	83
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	186	53
Tamsulosin Hcl	Tamsulosin Hcl	166	59
Ibuprofen	Ibuprofen	154	62
Albuterol Sulfate Hfa	Albuterol Sulfate	149	80
Hydrochlorothiazide	Hydrochlorothiazide	147	52
Furosemide	Furosemide	139	53
Gabapentin	Gabapentin	131	56
Fluticasone Propionate	Fluticasone Propionate	127	57
Metoprolol Tartrate	Metoprolol Tartrate	125	54
Metoprolol Succinate	Metoprolol Succinate	122	46
Famotidine	Famotidine	115	49
Metformin Hcl Er	Metformin Hcl	111	40
Trazodone Hcl	Trazodone Hcl	103	49
Lorazepam	Lorazepam	101	23
Sertraline Hcl	Sertraline Hcl	100	38
Tramadol Hcl	Tramadol Hcl	98	23
Atenolol	Atenolol	93	38
Cefadroxil	Cefadroxil	91	85
Alvesco	Ciclesonide	86	27
Omeprazole	Omeprazole	86	35
Doxycycline Monohydrate	Doxycycline Monohydrate	85	71
Pantoprazole Sodium	Pantoprazole Sodium	83	34
Simvastatin	Simvastatin	82	36
Potassium Chloride	Potassium Chloride	77	31
Metformin Hcl	Metformin Hcl	74	27
Terazosin Hcl	Terazosin Hcl	66	24
Azelastine Hcl	Azelastine Hcl	65	32
Jardiance	Empagliflozin	65	28
Glipizide	Glipizide	64	25
Alendronate Sodium	Alendronate Sodium	62	25
Finasteride	Finasteride	57	19
Ozempic	Semaglutide	57	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	23
Tizanidine Hcl	Tizanidine Hcl	55	22
Rosuvastatin Calcium	Rosuvastatin Calcium	53	22
Allopurinol	Allopurinol	52	22
Buspirone Hcl	Buspirone Hcl	52	15
Montelukast Sodium	Montelukast Sodium	52	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	48	35
Duloxetine Hcl	Duloxetine Hcl	46	20
Nortriptyline Hcl	Nortriptyline Hcl	45	16
Meloxicam	Meloxicam	42	20
Clonazepam	Clonazepam	41	suppressed
Prednisone	Prednisone	41	34
Carvedilol	Carvedilol	40	16
Pradaxa	Dabigatran Etexilate Mesylate	40	19
Pregabalin	Pregabalin	37	suppressed
Propranolol Hcl	Propranolol Hcl	36	13
Wixela Inhub	Fluticasone Propion/Salmeterol	36	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	35
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Fenofibrate	Fenofibrate	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	30	11
Spiriva Respimat	Tiotropium Bromide	30	13
Baclofen	Baclofen	29	suppressed
Clobetasol Propionate	Clobetasol Propionate	29	17
Donepezil Hcl	Donepezil Hcl	28	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	28	28
Ciprofloxacin Hcl	Ciprofloxacin Hcl	27	18
Colchicine	Colchicine	26	12
Eliquis	Apixaban	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Spironolactone	Spironolactone	25	11
Alprazolam	Alprazolam	24	suppressed
Amoxicillin	Amoxicillin	24	24
Lovastatin	Lovastatin	24	12
Humulin N	Insulin Nph Human Isophane	23	suppressed
Nystatin	Nystatin	23	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	23	suppressed
Trospium Chloride	Trospium Chloride	23	11
Breyna	Budesonide/Formoterol Fumarate	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Ondansetron Odt	Ondansetron	19	14
Acyclovir	Acyclovir	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	12
Triamcinolone Acetonide	Triamcinolone Acetonide	18	12
Azithromycin	Azithromycin	17	17
Fluocinonide	Fluocinonide	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Temazepam	Temazepam	17	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	13	13
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error